Skip to main content
Asim Roy, MD, Neurology, Dublin, OH

Asim Roy MD

Neurophysiology, Sleep Medicine


Physician

Join to View Full Profile
  • 4975 Bradenton AveDublin, OH 43017

  • Phone+1 614-766-0773

  • Fax+1 614-766-2599

Dr. Roy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2005 - 2006
  • OhioHealth/Riverside Methodist Hospital
    OhioHealth/Riverside Methodist HospitalInternship, Internal Medicine, 2001 - 2002
  • Northeast Ohio Medical University
    Northeast Ohio Medical UniversityClass of 2001

Certifications & Licensure

  • WV State Medical License
    WV State Medical License 2024 - 2027
  • KY State Medical License
    KY State Medical License 2024 - 2026
  • OH State Medical License
    OH State Medical License 2001 - 2026
  • PA State Medical License
    PA State Medical License 2008 - 2012
  • MA State Medical License
    MA State Medical License 2006 - 2009
  • DC State Medical License
    DC State Medical License 2003 - 2006
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Sleep Medicine
    American Board of Psychiatry and Neurology Sleep Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2013, 2015, 2017
  • CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2013, 2015, 2017
  • CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Narcolepsy Medication Lumryz Linked to Weight Loss
    Narcolepsy Medication Lumryz Linked to Weight LossAugust 20th, 2024
  • ZOLL Remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional Use
    ZOLL Remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional UseMay 25th, 2023
  • ZOLL Remedē System Receives FDA Approval for Sleep Apnoea Treatment
    ZOLL Remedē System Receives FDA Approval for Sleep Apnoea TreatmentMay 25th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: